Annals ofHepatitis

Volume: 2 - Number: 8 - July 15, 2008
Archive of Annals of Hepatitis

In this issue

Diabetes e Incretinas

Research article

Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future

Telbivudine: A new treatment for chronic hepatitis B.

Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis with Telbivudine or Adefovir

Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial.

Pharmacokinetics of telbivudine in subjects with various degrees of renal impairment

Telbivudine for the management of chronic hepatitis B virus infection.

[The efficacy and safety of telbivudine in korean patients with chronic hepatitis B.]

Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.

[Current data on the treatment of chronic hepatitis B.]

Oral antivirals for chronic hepatitis B.

Gateways to clinical trials.

[New German and American guidelines for therapy of hepatitis B. Discrepancies and similarities]

Gateways to clinical trials.

Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.

Customizing the management of chronic hepatitis B virus infection

Improving outcomes for patients with chronic hepatitis B.

[Advances in the treatment of hepatitis B]

Treatment paradigms on hepatitis B e antigen-negative chronic hepatitis B patients

Telbivudine for the treatment of chronic hepatitis B.

Telbivudine: a new option for the treatment of chronic hepatitis B.

[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52]

Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B.

New and emerging treatment of chronic hepatitis B.

Improving outcomes for patients with chronic hepatitis B.

Molecular mechanisms of resistance to antiviral therapy in patients with chronic hepatitis B.

Diagnosis and treatment of chronic hepatitis B: an update.

In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents

Telbivudine.

Enantio-selectivity of human nucleoside monophosphate kinases.

Seguimos creciendo para Brindar el mejor servicio

Buscador

Copyright © Dr. Mario I. Cámera .:. Powered by ForamenAlojado en ...